ASCO: Sunitinib Improves PFS in Small-Cell Lung Cancer

A randomized, phase II trial showed improved progression-free survival in small-cell lung cancer with maintenance sunitinib vs placebo following standard chemotherapy, according to results presented at the ASCO annual meeting in Chicago.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news